CLEC2A Antibody (Center) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the CLEC2A antibody detected the CLEC2A protein (arrow).
CLEC2A; KACL; C-type lectin domain family 2 member A; Keratinocyte-associated C-type lectin; Proliferation-induced lymphocyte-associated receptor
Key Feature
Clonality
Polyclonal
Isotype
Ig
Host Species
Rabbit
Tested Applications
WB
WB:1:100~500
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Gene Synonyms
KACL
Alternative Names
CLEC2A KACL C-type lectin domain family 2 member A Keratinocyte-associated C-type lectin Proliferation-induced lymphocyte-associated receptor
Molecular Weight(MW)
19972 Da
Function
Plays a role in modulating the extent of T-cell expansion. Enhances the expansion of TCR-stimulated T-cells by increasing their survival through enhanced expression of anti- apoptotic proteins. May modulate the capacity of T-cells to home to lymph nodes through SELL. Facilitates dedicated immune recognition of keratinocytes via interaction with its receptor KLRF2 by stimulating natural killer cell mediated cytotoxicity
Tissue Specificity
Mainly expressed in skin. Also expressed in keratinocytes, spleen, thymus, small intestine, peripheral blood monocytes, bone marrow, ovary, testis and skin. High expression in CD8(+), B-lymphocytes and naive CD4(+) T-cells. Restricted mostly to proliferating lymphocytes. Not detected in myeloid leukocytes or natural killer (NK) cells
Cellular Localization
Cell membrane; Single-pass type II membrane protein
CLEC2A Antibody (Center) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the CLEC2A antibody detected the CLEC2A protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.